Although sTNF-α/NF-κB pathway has been shown to mediate drug-resistance in different human cancers via TNFR [44–46], here we uncovered that tmTNF-α-mediated NF-κB activation via its reverse signaling is critical for DOX-resistance of breast cancer. Here, NFKB1 is linked to breast carcinoma.